Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites

European Journal of Endocrinology

Volumn 169, Issue 3, 2013, Pages 377-382

  Van Duinen, N ^a   Corssmit, E P M ^a   De Jong, W H A ^b   Brookman, D ^a   Kema, I P ^b   Romijn, J A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3 O METHYLDOPAMINE; ADRENALIN; BIOLOGICAL MARKER; DOPAMINE; METADRENALIN; NORADRENALIN; NORMETADRENALIN; VANILMANDELIC ACID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CAROTID BODY; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE EXCRETION; CATECHOLAMINE URINE LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GENOTYPE; GLOMUS JUGULARE; GLOMUS TYMPANICUM; HEAD AND NECK PARAGANGLIOMA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METABOLITE; MUTATIONAL ANALYSIS; PARAGANGLIOMA; PREDICTION; PRIORITY JOURNAL; SDAF2 GENE; SDHB GENE; SDHC GENE; SDHD GENE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TUMOR VOLUME; URINARY EXCRETION;

ADOLESCENT; ADULT; AGED; ALGORITHMS; BIOLOGICAL MARKERS; CATECHOLAMINES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DOPAMINE; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; METANEPHRINE; MIDDLE AGED; PARAGANGLIOMA; REPRODUCIBILITY OF RESULTS; TUMOR BURDEN; YOUNG ADULT;

EID: 84883332133     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0529     Document Type: Article

References (21)

1. DeLellis RA, Lloyd RV, Heitz PU & Eng C. In World Health Organisation Classification of Tumors, Pathology and Genetics of Endocrine Organs. Lyon: IARC Press, 2004.
2. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA & Young WF Jr. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. Journal of Clinical Endocrinology and Metabolism 2001 86 5210-5216. (doi:10.1210/jc.86.11.5210)
3. van Duinen N, Steenvoorden D, Kema IP, Jansen JC, Vriends AH, Bayley JP, Smit JW, Romijn JA & Corssmit EP. Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas. Journal of Clinical Endocrinology and Metabolism 2010 95 209-214. (doi:10.1210/jc.2009- 1632)
4. Zak FG & Lawson W. In The Paraganglionic Chemoreceptor System: Physiology, Pathology and Clinical Medicine, 1st edn. New York: Springer-Verlag, Inc., 1982.
5. Eisenhofer G, Lenders JW, LinehanWM,WaltherMM,Goldstein DS & KeiserHR. Plasma normetanephrine andmetanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. New England Journal of Medicine 1999b 340 1872-1879. (doi:10.1056/ NEJM199906173402404)
6. Lenders JW, Keiser HR, Goldstein DS, Willemsen JJ, Friberg P, Jacobs MC, Kloppenborg PW, Thien T & Eisenhofer G. Plasma metanephrines in the diagnosis of pheochromocytoma. Annals of Internal Medicine 1995 123 101-109. (doi:10.7326/0003-4819-123-2-199507150-00004)
7. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS & Eisenhofer G. Biochemical diagnosis of pheochromocytoma: which test is best? Journal of the American Medical Association 2002 287 1427-1434. (doi:10.1001/jama.287.11.1427)
8. Sawka AM, Jaeschke R, Singh RJ & Young WF Jr. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. Journal of Clinical Endocrinology and Metabolism 2003 88 553-558. (doi:10.1210/jc.2002-021251)
9. de Jong WH, Eisenhofer G, Post WJ, Muskiet FA, de Vries EG & Kema IP. Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamineproducing tumors. Journal of Clinical Endocrinology and Metabolism 2009 94 2841-2849. (doi:10.1210/jc.2009-0303)
10. Kema IP,Meiborg G, NagelGT, Stob GJ & Muskiet FA. Isotope dilution ammonia chemical ionization mass fragmentographic analysis of urinary 3-O-methylated catecholamine metabolites. Rapid sample clean-up by derivatization and extraction of lyophilized samples. Journal of Chromatography 1993 617 181-189.
11. Hall FT, Perez-Ordonez B, Mackenzie RG & Gilbert RW. Does catecholamine secretion from head and neck paragangliomas respond to radiotherapy? Case report and literature review. Skull Base 2003 13 229-234. (doi:10.1055/s-2004-817699)
12. Willemsen JJ, Ross HA, Wolthers BG, Sweep CG & Kema IP. Evaluation of specific high-performance liquid-chromatographic determinations of urinary metanephrine and normetanephrine by comparison with isotope dilution mass spectrometry. Annals of Clinical Biochemistry 2001 38 722-730. (doi:10.1258/0004563011900984)
13. de Jong WH, Graham KS, van der Molen JC, Links TP, Morris MR, Ross HA, de Vries EG & Kema IP. Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry. Clinical Chemistry 2007 53 1684-1693. (doi:10.1373/clinchem.2007.087114)
14. Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B,Wong N, Alpert LC et al. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. BMC Medical Genetics 2006 7 1. (doi:10.1186/1471-2350-7-1)
15. Taschner PE, Jansen JC, Baysal BE, Bosch A, Rosenberg EH, Brocker-Vriends AH, van Der Mey AG, van Ommen GJ, Cornelisse CJ & Devilee P. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes, Chromosomes & Cancer 2001 31 274-281. (doi:10.1002/gcc.1144)
16. Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams KT & Pacak K. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. Journal of Clinical Endocrinology and Metabolism 2005 90 2068-2075. (doi:10.1210/jc.2004- 2025)
17. Havekes B, van der Klaauw AA, Weiss MM, Jansen JC, van Der Mey AG, Vriends AH, Bonsing BA, Romijn JA & Corssmit EP. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas. Endocrine-Related Cancer 2009 16 527-536. (doi:10.1677/ERC-09-0024)
18. van Houtum WH, Corssmit EP, Douwes Dekker PB, Jansen JC, van Der Mey AG, Brocker-Vriends AH, Taschner PE, Losekoot M, Frolich M, Stokkel MPet al. Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas. European Journal of Endocrinology 2005 152 87-94. (doi:10.1530/eje.1.01833)
19. Eisenhofer G, Coughtrie MW & Goldstein DS. Dopamine sulphate: an enigma resolved. Clinical and Experimental Pharmacology & Physiology. Supplement 1999a 26 S41-S53.
20. Deutschbein T, Unger N, Jaeger A, Broecker-Preuss M, Mann K & Petersenn S. Influence of various confounding variables and storage conditions on metanephrine and normetanephrine levels in plasma. Clinical Endocrinology 2010 73 153-160. (doi:10.111/j.1365-2265.2009.03761.x)
21. Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR & Pacak K. Biochemical diagnosis of pheochromocytoma: how to distinguish true-from false-positive test results. Journal of Clinical Endocrinology and Metabolism 2003 88 2656-2666. (doi:10.1210/jc.2002-030005)